Related references
Note: Only part of the references are listed.Oxidative stress as a major culprit in kidney disease in diabetes
Josephine M. Forbes et al.
DIABETES (2008)
Action of epoxyeicosatrienoic acids on cellular function
Arthur A. Spector et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients
K Ohtoshi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet
YQ Zhou et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases
JD Imig
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Apigenin suppresses the expression of VEGF, an important factor for anglogenesis, in endothelial cells via degradation of HIF-1α protein
M Osada et al.
FEBS LETTERS (2004)
NAD(P)H oxidase participates in the signaling events in high glucose-induced proliferation of vascular smooth muscle cells
HS Lee et al.
LIFE SCIENCES (2003)
NADPH-cytochrome P-450 reductase in the plasma membrane modulates the activation of hypoxia-inducible factor 1
M Osada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Epoxygenase pathways of arachidonic acid metabolism
DC Zeldin
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Intrinsic signals in the sexually dimorphic circulating growth hormone profiles of the rat
AK Agrawal et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation
CJ Sinal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells
T Inoguchi et al.
DIABETES (2000)